Cargando…

Relaxin

Detalles Bibliográficos
Autor principal:	DeCherney, Alan H.
Formato:	Texto
Lenguaje:	English
Publicado:	1982
Materias:	Book Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596543/

Ejemplares similares

Cardiac Problems in Pregnancy. Diagnosis and Management of Maternal and Fetal Disease
por: DeCherney, Alan H.
Publicado: (1983)

Oxford Reviews of Reproductive Biology. Volume 4: 1982
por: DeCherney, Alan H.
Publicado: (1984)

In Vitro Fertilization and Embryo Transfer
por: DeCherney, Alan
Publicado: (1982)

Physiopathology of Hypophysial Disturbances and Diseases of Reproduction
por: DeCherney, Alan
Publicado: (1983)

Impact
por: Carpinello, Olivia, et al.
Publicado: (2020)

Relaxin'
Publicado: (1983)

In vitro fertilization and embryo transfer: a brief overview.
por: DeCherney, A. H.
Publicado: (1986)

Pregnancy outcomes in in vitro fertilization in 17-alpha-hydroxylase deficiency
por: van Oosbree, Annika, et al.
Publicado: (2023)

Conventional Laparoscopy Is the Better Option for Tubal Sterilization Reversal: A Closer Look at Tubal Reanastomosis
por: Madison, Anita, et al.
Publicado: (2021)

Relaxin as a natural agent for vascular health
por: Bani, Daniele
Publicado: (2008)

Relaxin-like Gonad-Stimulating Peptides in Asteroidea
por: Mita, Masatoshi
Publicado: (2023)

Laparoscopic management of ovarian cysts: an endocrinologist view.
por: Thornton, K. L., et al.
Publicado: (1991)

Phenotypic variations in X chromosome mutations: Two case reports
por: Dawkins, Josette C., et al.
Publicado: (2018)

Ovarian vein sampling, and serum and urine testosterone monitoring in ovarian Leydig cell tumors: A report of two cases
por: Whiteley, Grace, et al.
Publicado: (2019)

Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases
por: Aragón-Herrera, Alana, et al.
Publicado: (2022)

Relaxin’ the brain: a case for targeting the nucleus incertus network and relaxin‐3/RXFP3 system in neuropsychiatric disorders
por: Kumar, Jigna Rajesh, et al.
Publicado: (2016)

The effect of relaxin on the musculoskeletal system
por: Dehghan, F, et al.
Publicado: (2014)

Characterizing relaxin receptor expression and exploring relaxin’s effect on tissue remodeling/fibrosis in the human bladder
por: Diaz, Edward C., et al.
Publicado: (2020)

Biology of primate relaxin: A paracrine signal in early pregnancy?
por: Hayes, Eric S
Publicado: (2004)

Evolution of the relaxin-like peptide family
por: Wilkinson, Tracey N, et al.
Publicado: (2005)

Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
por: Bruell, Shoni, et al.
Publicado: (2017)

Characterization of relaxin 3 and its receptors in chicken: Evidence for relaxin 3 acting as a novel pituitary hormone
por: Lv, Can, et al.
Publicado: (2022)

Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design
por: D'Ercole, Annunziata, et al.
Publicado: (2022)

Fertility preservation before hematopoetic stem cell transplantation: a case series of women with GATA binding protein 2 deficiency, dedicator of cytokinesis 8 deficiency, and sickle cell disease
por: Aserlind, Alexandra, et al.
Publicado: (2020)

SUN-280 A Brute of a Case: Pituitary Apoplexy in a Patient Treated for Chronic Lymphocytic Leukemia with Ibrutinib
por: Guido, Paul Anthony, et al.
Publicado: (2020)

Response of Four Inbred Types of Mice to Relaxin
por: Wedemeyer, Phillips P.
Publicado: (1964)

Relaxin Protects Astrocytes from Hypoxia In Vitro
por: Willcox, Jordan M., et al.
Publicado: (2014)

Role of relaxin-2 in human primary osteosarcoma
por: Ma, Jinfeng, et al.
Publicado: (2013)

Physical fitness, serum relaxin and duration of gestation
por: Thorell, Eva, et al.
Publicado: (2015)

Cardioprotection Achieved Through Overexpression of Relaxin Receptors
por: Du, Xiao-Jun
Publicado: (2022)

Role of relaxin in diastasis of the pubic symphysis peripartum
por: Wang, Yan, et al.
Publicado: (2021)

The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease
por: Leysen, Hanne, et al.
Publicado: (2022)

Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2018)

Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290
por: Huang, Zaohua, et al.
Publicado: (2015)

Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis
por: McGowan, B. M., et al.
Publicado: (2008)

Relaxin, a pleiotropic vasodilator for the treatment of heart failure
por: Teichman, Sam L., et al.
Publicado: (2008)

Upregulation of Relaxin after Experimental Subarachnoid Hemorrhage in Rabbits
por: Kikkawa, Yuichiro, et al.
Publicado: (2014)

Relaxin reverses inflammatory and immune signals in aged hearts
por: Martin, Brian, et al.
Publicado: (2018)

Relaxin—when a successful super-drug is failing
por: Schlüter, Klaus-Dieter
Publicado: (2022)

Expression of Relaxin 3 in the Ovarian Follicle of Japanese Quail
por: Hoang, Khoi X., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kp3ls9v540j92g7k0np52s97p3